Author(s): Rebecca Agustine Kristian, Willy Sandhika, Heriyawati

Email(s): willysand@fk.unair.ac.id

DOI: 10.52711/0974-360X.2022.00273   

Address: Rebecca Agustine Kristian, Willy Sandhika*, Heriyawati
Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
*Corresponding Author

Published In:   Volume - 15,      Issue - 4,     Year - 2022


ABSTRACT:
Stress and inflammation have significant roles in tumor growth. Heat shock protein 70 (HSP70) is a molecular chaperone under stress conditions, such as carcinogenesis and cancer managements. Cyclooxygenase 2 (COX-2) is an inducible enzyme, regulated in response to variety of proinflammatory agents, like tumor promoters. The overexpression of HSP70 and COX-2 has been shown to be implicated in poor prognosis of cancer patients. There is a high degree of heterogeneity between tumours that can be seen from the different aggressiveness, such as tumor proliferation/growth (tumor size). All of the heterogeneity factors determine the risk of disease progression and therapeutic resistance. The purpose of this study was to analyze the expression of HSP70 and COX-2 in tumour proliferation (T stage) of invasive breast carcinoma of no special type (NST). Sixty samples were tested using an analytical observational design with cross sectional approach. We collected these samples from year 2016 to 2020 and divided them into 4 groups based on T stage (T1, T2, T3, T4). Immunohistochemical staining was performed to detect the expression of HSP70 and COX-2. There were significant differences of HSP70 (p= 0.030) and COX-2 (p=0,000) expression in the four groups There was no significant correlation between HSP70 and COX-2 expression (p=0,181) in the four groups. HSP70 and COX-2 have an important role in tumour proliferation therefore can determine prognosis and targeted therapy in breast cancer patients.


Cite this article:
Rebecca Agustine Kristian, Willy Sandhika, Heriyawati. Expression Level of HSP70 and COX-2 in Breast Cancer Proliferation in Dr. Soetomo General Hospital, Surabaya, Indonesia. Research Journal of Pharmacy and Technology. 2022; 15(4):1636-0. doi: 10.52711/0974-360X.2022.00273

Cite(Electronic):
Rebecca Agustine Kristian, Willy Sandhika, Heriyawati. Expression Level of HSP70 and COX-2 in Breast Cancer Proliferation in Dr. Soetomo General Hospital, Surabaya, Indonesia. Research Journal of Pharmacy and Technology. 2022; 15(4):1636-0. doi: 10.52711/0974-360X.2022.00273   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-4-39


REFERENCES:
1.    Fadholly A, Ansori ANM, Jayanti S, Proboningrat A, Kusala MKJ, Putri N, Rantam FA, et al. Cytotoxic effect of Allium cepa L. extract on human colon cancer (WiDr) cells: In vitro study. Research Journal of Pharmacy and Technology. 2019; 12(7): 3483-3486. doi.org/10.5958/0974-360X.2019.00591.2
2.    Fadholly A, Ansori ANM, Sucipto TH. An overview of naringin: Potential anticancer compound of Citrus fruits. Research Journal of Pharmacy and Technology. 2020; 13(11): 5613-5619. doi.org/10.5958/0974-360X.2020.00979.8
3.    Proboningrat A, Ansori ANM, Fadholly A, Putri N, Kusala MKJ, Achmad AB. First report on the cytotoxicity of Pinus merkusii bark extract in WiDr, a human colon carcinoma cell line. Research Journal of Pharmacy and Technology. 2021; 14(3): 1685-1688. doi.org/10.5958/0974-360X.2021.00299.7
4.    Jose BE, Muralidharan P. Effect of Azima tetracantha Lam on human breast cancer cells MCF-7. Research Journal of Science and Technology. 2019; 11(2): 109-112. doi.org/10.5958/2349-2988.2019.00017.2
5.    Aloss K, Jdeed S, Alshehabi Z. Detecting the role of CCR7-CCL21/CCL19 axis in breast cancer progression and lymph node metastasis incidence. Research Journal of Pharmacy and Technology. 2018; 11(1): 231-235. doi.org/10.5958/0974-360X.2018.00043.4
6.    Yi M, Ryu YM. The effects of breast health education in women with breast cancer. Research Journal of Pharmacy and Technology. 2017; 10(7): 2295-2302. doi.org/10.5958/0974-360X.2017.00407.3
7.    Swarnalatha Y. Isolation of flavonoids and their anticancer activity from Sphaeranthus amaranthoides in A549 cell line. Research Journal of Pharmacy and Technology. 2015; 8(4): 462-467. doi.org/10.5958/0974-360X.2015.00077.3
8.    Boudesco C, Cause S, Jego G, Garrido C. Hsp70: A cancer target inside and outside the cell. Methods in Molecular Biology. 2018; 1709: 371–396. doi.org/10.1007/978-1-4939-7477-1_27.
9.    Ravi A, Gokul RM, Arunachalam S, Sathiavelu M. Marine environment: A potential source for anticancer drugs. Research Journal of Pharmacy and Technology. 2017; 10(5): 1543-1550. doi.org/10.5958/0974-360X.2017.00272.4
10.    Jayashree V, Velraj M. Breast cancer and various prognostic biomarkers for the diagnosis of the disease: A review. Research Journal of Pharmacy and Technology. 2017; 10(9): 3211-3216. doi.org/10.5958/0974-360X.2017.00570.4
11.    Asaad RA. Hormone receptor status and its relation to c-reactive protein and other prognostic factors in breast cancer in Jableh-Syria. Research Journal of Pharmacy and Technology. 2017; 10(9): 3003-3010. doi.org/10.5958/0974-360X.2017.00532.7
12.    Calderwood SK. Heat shock proteins and cancer: intracellular chaperones or extracellular signalling ligands? Philos Trans R Soc Lond B Biol Sci. 2018; 373(1738): 20160524. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 373(1738), 20160524. doi.org/10.1098/rstb.2016.0524
13.    Padmini R, Sitrarasi R, Razia M. Molecular docking studies of bioactive compounds from Allium sativum against EML4-ALK receptor. Research Journal of Pharmacy and Technology. 2017; 10(11): 3741-3747. doi.org/10.5958/0974-360X.2017.00679.5
14.    Vijay A, Sona VP, Radha A, Moorthi PV. A review on advancement perspectives in cervical cancer. Research Journal of Pharmacy and Technology. 2017; 10(12): 4410-4414. doi.org/10.5958/0974-360X.2017.00813.7
15.    Chen Z, Zhang P, Xu Y, Yan J, Liu Z, Lau WB, Lau B, et al. Surgical stress and cancer progression: the twisted tango. Molecular Cancer. 2019; 18(1): 132. doi.org/10.1186/s12943-019-1058-3
16.    Albakova Z, Armeev GA, Kanevskiy LM, Kovalenko EI, Sapozhnikov AM. HSP70 multi-functionality in cancer. Cells. 2020; 9(3): 587. doi.org/10.3390/cells9030587
17.    Bandil V, Gupta JK, Goyal M. Vinorelbine: A potential breakthrough in cancer therapy. Research Journal of Pharmacy and Technology. 2021; 14(3): 1823-1827. doi.org/10.5958/0974-360X.2021.00323.1
18.    Ansori ANM, Fadholly A, Kharisma VD, Nugraha AP. Therapeutic potential of Newcastle disease virus for cancer therapy: A mini review. Biochemical and Cellular Archives. 2020; 20: 2827-2832. doi.org/10.35124/bca.2020.20.S1.3023
19.    Widyananda MH, Pratama SK, Samoedra RS, Sari FN, Kharisma VD, Ansori ANM, Antonius YA. Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins. Journal of Pharmacy and Pharmacognosy Research. 2021; 9(4): 484-496.
20.    Juhasz K, Lipp AM, Nimmervoll B, Sonnleitner A, Hesse J, Haselgruebler T, Balogi Z. The complex function of hsp70 in metastatic cancer. Cancers. 2013; 6(1): 42-66. Cancers. 2013; 6(1): 42–66. doi.org/10.3390/cancers6010042
21.    Fadholly A, Ansori ANM, Proboningrat A, Nugraha AP, Iskandar RPD, Rantam FA, Sudjarwo SA. Apoptosis of HeLa cells via caspase-3 expression induced by chitosan-based nanoparticles of Annona squamosa leaf extract: In vitro study. Indian Journal of Pharmaceutical Education and Research. 2020; 54(2): 416-421. doi.org/10.5530/ijper.54.2.47
22.    Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: A review. Journal of Cellular Physiology. 2019; 234(5): 5683–5699. doi.org/10.1002/jcp.27411
23.    Jagadish N, Agarwal S, Gupta N, Fatima R, Devi S, Kumar V, Suri V, et al. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer. Journal of Experimental & Clinical Cancer Research: CR. 2016; 35(1): 150. doi.org/10.1186/s13046-016-0425-9
24.    Solanki R, Agrawal N, Ansari M, Jain S, Jindal A. COX-2 Expression in breast carcinoma with correlation to clinicopathological parameters. Asian Pacific Journal of Cancer Prevention: APJCP. 2018; 19(7): 1971–1975. doi.org/10.22034/APJCP.2018.19.7.1971
25.    Xu F, Li M, Zhang C, Cui J, Liu J, Li J, Jiang H. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: A Meta-Analysis. Oncotarget. 2017; 8(4): 6003-6012. doi.org/10.18632/oncotarget.13990
26.    Kumar S, Stokes J, Singh UP, Scissum Gunn K, Acharya A, Manne U, Mishra M. Targeting Hsp70: A possible therapy for cancer. Cancer Letters. 2016; 374(1): 156-166. doi.org/10.1016/j.canlet.2016.01.056
27.    Pang LY, Hurst EA, Argyle DJ. Cyclooxygenase-2: A role in cancer stem cell survival and repopulation of cancer cells during therapy. Stem Cells International. 2016; 2016: 2048731. doi.org/10.1155/2016/2048731
28.    Moon JJ, Lu A, Moon C. Role of genomic instability in human carcinogenesis. Experimental Biology and Medicine. 2019; 244(3): 227–240. doi.org/10.1177/1535370219826031

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available